BiondVax Pharmaceuticals, a publicly-traded company (TASE: BNDX ) (Nasdaq: BVXV ) located in the Weizmann Science Park in Ness-Ziona (Israel), is dedicated to the development of a novel Universal Influenza Vaccine.
legal_form: BiondVax, company